Filing Details

Accession Number:
0001209191-15-010598
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-09 07:37:37
Reporting Period:
2015-02-05
Filing Date:
2015-02-09
Accepted Time:
2015-02-09 07:37:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899460 Mannkind Corp MNKD Pharmaceutical Preparations (2834) 133607736
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1309429 Diane Palumbo 28903 North Avenue Paine
Valencia CA 91355
Vice President, Human Resource No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.01 Par Value Acquisiton 2015-02-05 29,833 $2.41 58,938 No 4 M Direct
Common Stock, $.01 Par Value Disposition 2015-02-05 29,833 $6.95 29,105 No 4 S Direct
Common Stock, $.01 Par Value Acquisiton 2015-02-05 60,000 $1.69 89,105 No 4 M Direct
Common Stock, $.01 Par Value Disposition 2015-02-05 60,000 $6.95 29,105 No 4 S Direct
Common Stock, $.01 Par Value Acquisiton 2015-02-05 60,000 $1.69 89,105 No 4 M Direct
Common Stock, $.01 Par Value Disposition 2015-02-05 60,000 $6.95 29,105 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $0.01 Par Value Employee Stock Option Disposition 2015-02-05 29,833 $0.00 29,833 $2.41
Common Employee Stock Option Disposition 2015-02-05 60,000 $0.00 60,000 $1.69
Common Employee Stock Option Disposition 2015-02-05 60,000 $0.00 60,000 $1.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,918 2012-08-17 2021-08-17 No 4 M Direct
0 2014-05-17 2022-05-17 No 4 M Direct
0 2014-05-17 2022-05-17 No 4 M Direct
Footnotes
  1. Transaction occurred pursuant to Rule 10B5-1 Plan.